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Introduction
The mitochondr ia l  DNA (mtDNA) 
m.8993T>G transversion in the MT-ATP6 
gene provokes a p.L156R substitution 
in transmembrane helix 4 (TMH4) of the 
p.MT-ATP6 subunit. This polypeptide is an 
ATP synthase (complex V, CV) component 
of the oxidative phosphorylation system 
(OXPHOS). The amino acid position 156 
is located in the channel used by protons to 
enter the mitochondrial matrix and power 
ATP synthesis. The m.8993T>G mutation 
is associated with maternally inherited Leigh 
syndrome (MILS) and neurogenic muscle 
weakness, ataxia, and retinitis pigmentosa 
(NARP) (Holt et al. 1990; Thorburn and 
Rahman 1993). In general, NARP is caused 
by moderate levels of the m.8993T>G 
mutation, whereas individuals with mutant 
loads > 90% have MILS (Tatuch et al. 1992). 
However, in some families, oligosymp-
tomatic children share the same mutation 
load as those of symptomatic siblings (Enns 
et al. 2006), and high mutation loads are 
not always associated with signs of MILS or 
NARP (Degoul et al. 1995; Mkaouar-Rebai 
et al. 2009; Tsao et al. 2001). Similarly to 
many other pathological mutations (Cooper 
et al. 2013; Lake et al. 2015), other factors 
are likely involved in the phenotypic differ-
ences among individuals with the same 
m.8993T>G mutation load.
Other pathological mutations in mtDNA 
genes have been reported in MILS patients 
(Montoya et al. 2009; Ruhoy and Saneto 
2014; Thorburn and Rahman 1993). Thus, 
polymorphic variation in these genes may 
influence the m.8993T>G phenotype. 
Indeed, the mtDNA genetic background 
(mtDNA haplogroups) plays an important 
role in modulating the biochemical defects 
and the clinical outcome by altering the risk 
of MILS caused by m.8993T>G (D’Aurelio 
et al. 2010; Hao et al. 2013). Moreover, 
many other pathological mutations in nuclear 
DNA (nDNA) genes have been described in 
Leigh syndrome (LS) patients (Ruhoy and 
Saneto 2014). For example, a mutated mito-
chondrial aminoacyl-transfer RNA (tRNA) 
synthetase was described in a patient with LS 
(Schwartzentruber et al. 2014). Interestingly, 
a patient with MILS had a homoplasmic 
mutation in the tRNAVal, and his clinically 
normal mother was also homoplasmic mutant 
(McFarland et al. 2002). It was recently 
shown that overexpression of mitochondrial 
valyl-tRNA synthetase can restore the steady-
state levels of the mutated tRNAVal. Thus, 
interindividual variations of this synthetase 
may underlie clinical differences (Rorbach 
et al. 2008). Therefore, polymorphic varia-
tion in nDNA genes may influence the 
m.8993T>G phenotype.
In addition to nuclear and mitochondrial 
genetic factors, environmental stimuli may 
modify the phenotype of the m.8993T>G 
mutation. Certain chemicals trigger the 
appearance of pathological phenotypes associ-
ated with mtDNA mutations. For example, 
individuals harboring the m.1555A>G tran-
sition in the MT-RNR1 gene for 12S ribo-
somal RNA (rRNA) suffer nonsyndromic 
hearing loss when exposed to aminoglyco-
sides (Prezant et al. 1993). Furthermore, 
occupational exposure to n-hexane and 
other solvents precipitated visual failure in 
a Leber hereditary optic neuropathy patient 
with the m.11778G>A mutation (Carelli 
et al. 2007). Previous reports suggest that the 
CV proton channel, particularly the p.MT-
ATP6 subunit, is the target site for organotin 
compounds, including tributyltin chloride 
(TBTC) (von Ballmoos et al. 2004). These 
compounds contaminate human food and 
water (Kotake 2012). Therefore, it is possible 
that TBTC affects the expressivity of the 
m.8993T>G mutation.
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Background: The oxidative phosphorylation system (OXPHOS) includes nuclear chromosome 
(nDNA)– and mitochondrial DNA (mtDNA)–encoded polypeptides. Many rare OXPHOS 
disorders, such as striatal necrosis syndromes, are caused by genetic mutations. Despite important 
advances in sequencing procedures, causative mutations remain undetected in some patients. 
It is possible that etiologic factors, such as environmental toxins, are the cause of these cases. 
Indeed, the inhibition of a particular enzyme by a poison could imitate the biochemical effects of 
pathological mutations in that enzyme. Moreover, environmental factors can modify the penetrance 
or expressivity of pathological mutations.
oBjectives: We studied the interaction between mitochondrially encoded ATP synthase 6 
(p.MT-ATP6) subunit and an environmental exposure that may contribute phenotypic differ-
ences between healthy individuals and patients suffering from striatal necrosis syndromes or other 
mitochondriopathies.
Methods: We analyzed the effects of the ATP synthase inhibitor tributyltin chloride (TBTC), 
a widely distributed environmental factor that contaminates human food and water, on trans-
mitochondrial cell lines with or without an ATP synthase mutation that causes striatal necrosis 
syndrome. Doses were selected based on TBTC concentrations previously reported in human whole 
blood samples.
results: TBTC modified the phenotypic effects caused by a pathological mtDNA mutation. 
Interestingly, wild-type cells treated with this xenobiotic showed similar bioenergetics when 
compared with the untreated mutated cells.
conclusions: In addition to the known genetic causes, our findings suggest that environmental 
exposure to TBTC might contribute to the etiology of striatal necrosis syndromes.
citation: López-Gallardo E, Llobet L, Emperador S, Montoya J, Ruiz-Pesini E. 2016. Effects of 
tributyltin chloride on cybrids with or without an ATP synthase pathologic mutation. Environ 
Health Perspect 124:1399–1405; http://dx.doi.org/10.1289/EHP182
Lopez-Gallardo et al.
1400 volume 124 | number 9 | September 2016 • Environmental Health Perspectives
Methods
Transmitochondrial Cell Line 
Construction, Characterization 
and Functional Investigations
To homogenize nuclear and environmental 
factors, we built transmitochondrial cell 
lines (cytoplasmic hybrids or cybrids) with 
osteosarcoma 143B or adenocarcinoma A549 
rho0 nuclear backgrounds using patient and 
control platelets (Chomyn et al. 1994). All 
samples were collected with written informed 
consent, and the Ethics Review Committees 
of the involved hospitals and the Government 
of Aragón approved the study [Comité 
Ético de Investigación Clínica de Aragón 
(CEICA) 11/2010].
The cybrids were grown in Dulbecco’s 
modified Eagle medium (DMEM) containing 
glucose (1 g/L), pyruvate (0.11 g/L) and 
fetal bovine serum (5%) with no antibiotics 
(Llobet et al. 2015a).
For molecular cytogenetic analysis, cells 
were exposed to colchicine (0.5 μg/mL) for 
4 hr at 37°C and were harvested routinely. 
Metaphase cells were prepared following 
a conventional cytogenetic protocol for 
methanol:acetic acid (3:1)–fixed cells. 
Approximately 20 metaphase cells were 
captured and analyzed for each cell line. The 
genetic fingerprint of the cybrid cell lines was 
determined using an AmpFLSTR® Identifiler® 
PCR Amplification Kit (Life Technologies) 
and an ABI Prism 3730xl DNA analyzer 
(Applied Biosystems). These genetic finger-
prints were compared with those from the 
American Type Culture Collection (ATCC) 
cell lines. To confirm the nucleotide at the 
m.8993 position, a polymerase chain reaction–
restriction fragment length polymorphism 
(PCR-RFLP) analysis was performed (López-
Gallardo et al. 2014). mtDNA sequences were 
obtained using a BigDye Terminator v.3.1 
Cycle Sequencing Kit (Applera Rockville) 
and an ABI Prism 3730xl DNA analyzer. 
The revised Cambridge reference sequence 
(GenBank NC_012920) and an mtDNA 
phylogenetic tree were used to locate muta-
tions and to define mtDNA haplogroups (van 
Oven and Kayser 2009), respectively. The level 
of peroxisome proliferator-activated receptor 
gamma (PPARγ) messenger RNA (mRNA) 
was determined in triplicate using reverse 
transcriptase–quantitative PCR (RT-qPCR) 
and the One-Step Real-Time system (Applied 
Biosytems). The expression levels were normal-
ized using 18S rRNA. The ΔCt method was 
used to calculate fold expression. StepOne 
software v.2.0 (Applied Biosystems) was used 
for data analysis.
Analyses of oxygen consumption, ATP, 
and H2O2 levels were performed in triplicate 
according to previously described protocols 
(Gómez-Durán et al. 2010). Determination 
of the mitochondrial inner membrane poten-
tial (MIMP) was performed using a Mito-ID 
Membrane Potential Detection Kit (Enzo 
Life Sciences). Fluorescence microscopy 
was performed on live cells using a Floyd 
Cell imaging station (Life Technologies). 
Isocitrate dehydrogenase (IDH) activity was 
determined using a commercial Isocitrate 
Dehydrogenase Colorimetric Assay Kit 
(Abcam®) according to the manufacturer’s 
instructions. Briefly, 1 × 106 cells grown in 
DMEM were lysed in 200 μL of an assay 
buffer provided in the kit. The lysate was 
centrifuged at 13,000 × g for 10 min, and 
the cleared supernatant was used for the 
assay. NAD+ was used as the substrate for 
the NAD-IDH assay. Measurements were 
obtained using a NovoStar MBG Labtech 
microplate instrument.
In a previous study, 25 of 32 blood 
donors from the state of Michigan, USA, 
showed detectable concentrations of TBT in 
whole blood samples (Kannan et al. 1999). 
The observed range, 8.3–293 nM, encom-
passes the TBTC concentrations used in 
the present study. When required, TBTC 
(Sigma-Aldrich) or oligomycin (OLI) 
(Sigma-Aldrich), another CV inhibitor, was 
dissolved in ethanol and added to the respira-
tion medium during the oxygen consump-
tion determination and to the medium for 
ATP, MIMP, H2O2, or IDH determination 
during the 2-hr, 15-min, 30-min, or 24-hr 
 incubation periods, respectively.
Statistical Analysis
The statistical package StatView 6.0 (SAS 
Institute Inc.) was used to perform all statistical 
analyses. The data are presented as the mean 
and standard deviation. At least three analyses 
were performed for each parameter. An 
unpaired two-tailed t-test was used to compare 
parameters. Linear regression analyses were 
performed, and linear regression equations and 
regression coefficients are indicated for TBTC 
concentrations versus oxygen consumption, 
ATP amount, or H2O2 level. p-Values < 0.05 
were considered statistically significant.
Results
Characterization of the Cybrid Cell 
Lines
Five cybrid cell lines were built. Two cybrids 
within the adenocarcinoma A549 nuclear 
background were intended to harbor the 
m.8993T (Awt) or m.8993G (Am) mtDNA 
alleles. The other three cybrids within the 
osteosarcoma 143B nuclear background were 
also intended to harbor the m.8993G (Om) 
or m.8993T mtDNA alleles. For the osteo-
sarcoma 143B m.8993T cells, a nonisogenic 
wild-type cybrid was first generated (Owt). 
An isogenic cybrid was produced (Owti) 
after we obtained platelets from the wild-type 
mother of the patient harboring the mutation.
Karyotyping was used to verify that the 
nuclear backgrounds were equivalent. Thus, 
the Am and Awt cybrids shared the modal 
number of chromosomes (60) and several 
chromosomal abnormalities [del(2p21), 
+der(6)t(1;6)(q24–25?;q23), +der(7)delq32?, 
del(11q23)] (see Figure S1). The modal 
number of chromosomes differed in Owt (66), 
Owti (69), and Om (70/71) cybrids; however, 
these numbers are similar to those previ-
ously published in other osteosarcoma 143B 
transmitochondrial cell lines (Gómez-Durán 
et al. 2010). These cybrids shared several 
chromosomal abnormalities [+i(7p), +der(7)
t(1;7)(q25;q32)[2], +der(12)add(q24.3)]. To 
confirm the celluar origin of our cybrids and 
the equivalence of their nuclear backgrounds, 
we determined the nuclear genetic finger-
print of 16 short tandem repeats (STRs) (see 
Table S1). Adenocarcinoma A549 cybrids did 
not differ in their STR markers and did not 
vary from the 9 STR markers characterized 
from the ATCC adenocarcinoma A549 cell 
line. The same was true for the osteosarcoma 
143B cybrids and the ATCC osteosarcoma 
143B cell line.
Next, we confirmed the mtDNA alleles 
of the cybrids using PCR-RFLP. The 
m.8993T>G mutation caused the amplicon to 
be cut into two fragments, and the wild-type 
amplicon was not digested (see Figure S2). To 
rule out the presence of mtDNA nondefining 
haplogroup (private) mutations that can 
affect the bioenergetic phenotypes of these 
cybrids, we sequenced the complete mtDNA 
(GenBank JN635299, KJ742713, KJ742715, 
KT002148, KT002149) (see Table S2). Owt 
cybrids contained two nonsynonymous private 
mutations: m.3387T>A, provoking a p.MT-
ND1:I27M substitution, and m.14189A>G, 
causing a p.MT-ND6:V162A change. Am 
cybrids contained one nonsynonymous private 
mutation: m.9194A>G, producing a p.MT-
ATP6:H223R replacement. These mutations 
have previously been found zero, nine, and 
four times, respectively, in 29,867 mtDNA 
sequences (GenBank, February 2015). 
However, the affected positions show low 
evolutionary conservation (23.5%, 13.9%, 
and 14.1% in 5,165, 5,177, and 4,925 
eukaryote species, respectively; GenBank, 
February 2015) when compared with the 
conservation of the p.MT-ATP6:L156 amino 
acid replacement (99.0% in 4,925 Eukaryota 
species) that causes MILS or NARP. This lack 
of evolutionary conservation suggests that 
these mutations would have little or no impact 
on phenotype. Therefore, we assumed that the 
m.8993T>G transversion was responsible for 
the major phenotypic differences between the 
mutant and wild-type cybrids that had the 
same nuclear background.
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It has previously been reported that 
m.8993T>G mutant cybrids with the osteo-
sarcoma 143B nuclear background showed 
reduced oxygen consumption (D’Aurelio et al. 
2010; López-Gallardo et al. 2014; Pallotti 
et al. 2004), decreased ATP levels (D’Aurelio 
et al. 2010; Fujita et al. 2007; López-Gallardo 
et al. 2014; Pallotti et al. 2004; Sgarbi et al. 
2009; Vazquez-Memije et al. 2009), dimin-
ished MIMP (López-Gallardo et al. 2014), 
and increased reactive oxygen species (ROS) 
(López-Gallardo et al. 2014; Wojewoda 
et al. 2010). Oxygen consumption was also 
reported to be reduced in m.8993T>G 
mutant cybrids with a cervical cancer HeLa 
EB8 nuclear background (Shidara et al. 
2005). To confirm that the mutant cybrids 
used in the present study also showed reduced 
OXPHOS capability, we analyzed these mito-
chondrial variables. We found that oxygen 
consumption was significantly decreased in 
both Om and Am cybrids (see Figure S3A 
and Table S3). The ATP levels were signifi-
cantly diminished only in the Om cybrids. In 
contrast with the Om cybrids, in which H2O2 
levels were significantly higher than in Owti, 
H2O2 levels were decreased in Am cybrids 
compared with Awt, albeit not significantly so. 
It was previously reported that mitochondria 
in an m.8993T>G mutant osteosarcoma 143B 
cybrid generated MIMP at the same levels 
as the parental wild-type cells (Wojewoda 
et al. 2012). We found that, similar to the 
Om cybrids (López-Gallardo et al. 2014), 
the MIMP in Am cybrids was reduced (see 
Figure S3B), although this result was based on 
visual assessment of a single sample.
These results confirm that the  biochemical 
phenotypes of our cybrids were similar to 
those of other reported cybrids with the 
m.8993T>G mutation.
Effects of Tributyltin Chloride on 
Cybrids
It was previously reported that mitochon-
drial respiration was significantly decreased 
in mice treated with TBTC (Ueno et al. 
2003) and that oxygen consumption in 
human adipose tissue–derived stem cells 
(hASCs) was decreased in reponse to 100 nM 
TBTC (Llobet et al. 2015b). We found that 
TBTC at concentrations ≥ 10 nM signifi-
cantly decreased oxygen consumption in 
Om cybrids when compared with untreated 
cybrids (Figure 1A). TBTC ≥ 50 nM was 
required to significantly reduce oxygen 
consumption in Owt cybrids. There were 
negative and significant correlations between 
TBTC concentration and oxygen consump-
tion in Owt [linear regression coefficient 
(β) for the change in %O2 consumption 
with a 1-nM increase in TBTC = –0.45; 
R 2 = 0.924; p < 0.0001] and Om (TBTC 
β = –0.41; R2 = 0.796; p < 0.0001) cybrids. 
For the majority of TBTC concentrations 
between 20 and 90 nM, the reduction in 
oxygen consumption in response to TBTC 
was significantly greater in Om than in 
Owt cybrids.
Additionally, TBTC at concentrations 
≥ 20 nM significantly decreased oxygen 
consumption in Am cybrids when compared 
with untreated cybrids (Figure 1B). TBTC 
≥ 70 nM significantly reduced oxygen 
consumption in Awt cybrids; however, 40 nM 
TBTC also reduced this parameter. There 
were negative and significant correlations 
between TBTC concentration and oxygen 
consumption in Awt (TBTC β = –0.35; 
R 2 = 0.876; p < 0.0001) and Am cybrids 
(TBTC β = –0.46; R2 = 0.956; p < 0.0001). 
For TBTC concentrations between 30 and 
90 nM, the reduction in oxygen consumption 
in response to TBTC was significantly greater 
in Am than in Awt cybrids. The decrease in 
oxygen consumption in response to 50 and 
60 nM TBTC was significantly greater in 
Om than in Am cybrids, and the decrease in 
oxygen consumption in response to 90 and 
100 nM TBTC was significantly greater in 
Owt than in Awt cybrids.
Previous reports showed that 100 nM 
TBT decreased ATP levels in human embry-
onic carcinoma NT2/D1 cells (Yamada 
et al. 2014). We found that at concentra-
tions ≥ 15 nM, TBTC significantly decreased 
ATP levels in Om and Am cybrids when 
compared with untreated cybrids (Figure 2). 
Furthermore, Owti and Awt cybrids treated 
with TBTC ≥ 60 nM and TBTC ≥ 90 nM, 
respectively, showed significantly reduced 
ATP levels. These levels were also reduced 
in Owti cybrids treated with 15 nM TBTC. 
There were negative and significant corre-
lations between TBTC concentrations and 
ATP levels in Owti (TBTC β = –0.17; 
R 2 = 0.810; p = 0.0374), Om (TBTC 
β = –0.30; R 2 = 0.850; p = 0.0234), and 
Am cybrids (TBTC β = –0.38; R 2 = 0.780; 
p = 0.0491), but not in Awt cybrids (TBTC 
β = –0.11; R2 = 0.382; p = 0.3076). Om and 
Am cybrids were more susceptible to TBTC 
concentrations ≥ 15 or ≥ 30 nM, respec-
tively, than the wild-type cells. The decrease 
Figure 1. Oxygen consumption by osteosarcoma 143B (A) and adenocarcinoma A549 (B) cybrids. The 
dashed line (100%) represents the mean value in each of the untreated cybrids. The bars indicate the 
percentage of tributyltin chloride (TBTC)-treated cybrids. Error bars represent the standard deviation. Am, 
adenocarcinoma with mutation; Awt, wild-type adenocarcinoma; Om, osteosarcoma with mutation; Owt, 
nonisogenic wild-type osteosarcoma. 
*p < 0.05 versus the same untreated cybrid. #p < 0.05 versus the wild-type cybrid from the same nuclear background at 
the same TBTC concentration. †p < 0.05 for Om versus Am or Owt versus Awt at the same TBTC concentration.
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in ATP levels in response to 90 nM TBTC 
was significantly greater in Am than in Om 
cybrids. There were no significant differences 
in ATP levels between Owti and Awt cybrids 
at any TBTC dose.
In a previous study, MIMP was dimin-
ished in mouse thymocytes treated with 
10 nM TBTC (Sharma and Kumar 2014). 
In the present study, visual assessment of a 
single sample suggested that at concentrations 
≥ 30 nM, TBTC decreased the MIMP of the 
Am cybrid. However, a TBTC concentration 
≥ 60 nM was required to affect the MIMP of 
the Awt cybrid (Figure 3).
In a previous study, 10-nM concentra-
tions of TBTC increased H2O2 production 
in mouse thymocytes (Sharma and Kumar 
2014). However, in other studies, ≤ 300 nM 
TBTC did not increase H2O2 levels in a 
mixture of dissociated cells from different 
parts of rat brain (Mitra et al. 2014), and 
100 nM TBTC did not change the H2O2 
production in hASCs (Llobet et al. 2015b). 
We found that ≥ 30 nM TBTC significantly 
decreased H2O2 production in Owti and 
Om cybrids when compared with untreated 
cybrids (Figure 4). There were negative and 
significant correlations between TBTC 
concentrations and H2O2 levels in Owti 
(TBTC β = –0.56; R2 = 0.969; p = 0.0006) 
and Om (TBTC β = –0.58; R 2 = 0.915; 
p = 0.0071) cybrids.
Tributyltin Target
Several TBTC targets have been proposed. 
It has been reported that TBTC can activate 
genomic pathways by binding PPARγ 
(Kanayama et al. 2005). Thus, the different 
susceptibilities of mutant and wild-type 
cybrids to TBTC may be PPARγ-mediated. 
Osteosarcoma 143B and adenocarcinoma 
A549 cells express the PPARγ gene (Haydon 
et al. 2002; Li et al. 2014). However, we did 
not observe significant differences in PPARγ 
mRNA expression between mutant and wild-
type cybrids (see Figure S3A). Therefore, this 
target does not explain our results.
A previous report showed that 100 nM 
TBTC decreased IDH activity in human 
embryonic carcinoma NT2/D1 cells. These 
results suggest that IDH is a novel target of 
TBTC (Yamada et al. 2014). IDH is a mito-
chondrial enzyme from the tricarboxylic acid 
cycle that produces NADH. This compound 
is reoxidized in the OXPHOS electron trans-
port chain and increases oxygen consumption 
and MIMP and ATP production. Therefore, 
inhibition of IDH by TBTC would decrease 
all of these parameters. However, we previ-
ously found that 100 nM TBTC increased 
IDH activity in hASCs (Llobet et al. 2015b). 
To assess IDH inhibition, we tested the 
effects of TBTC on osteosarcoma 143B 
cybrids. At TBTC concentrations ≥ 20 nM, 
Owti IDH activity did not differ signifi-
cantly from that of untreated Owti cells. At 
concentrations of 20 and 100 nM, TBTC 
significantly increased IDH activity in the 
Om cybrid compared with untreated Om 
cells (Figure 5). These data suggest that 
NADH accumulation caused by OXPHOS 
dysfunction in mutant cybrids can provoke 
an abnormal increase in isocitrate and a 
compensatory expression of IDH. Indeed, 
the mutant cybrid showed significantly higher 
IDH activity than the Owti cybrid (see 
Figure S3A). Thus, inhibition of IDH does 
not explain our results.
CV is the third proposed target of TBTC. 
In previous studies, it was shown that, simi-
larly to TBTC, at concentrations ≥ 49 nM, 
the CV inhibitor OLI decreased oxygen 
consumption in osteosarcoma 143B cybrids 
Figure 2. ATP levels in osteosarcoma 143B and adenocarcinoma A549 cybrids. The dashed line (100%) 
represents the mean value in each of the untreated cybrids. The bars indicate the percentage of tributyltin 
chloride (TBTC)-treated cybrids. Error bars represent the standard deviation. Am, adenocarcinoma with 
mutation; Awt, wild-type adenocarcinoma; Om, osteosarcoma with mutation; Owti, isogenic wild-type 
osteosarcoma.
*p < 0.05 versus the same untreated cybrid. #p < 0.05 versus the wild-type cybrid from the same nuclear background at 
the same TBTC concentration. †p < 0.05 for Om versus Am at the same TBTC concentration.
Figure 3. Mitochondrial inner membrane potential (MIMP) in single samples of tributyltin chloride (TBTC)-
treated adenocarcinoma A549 cybrids. Reduced red staining corresponds to lower MIMP. Am, adenocar-
cinoma with mutation; Awt, wild-type adenocarcinoma.
Figure 4. Hydrogen peroxide (H2O2) production in 
tributyltin chloride (TBTC)-treated osteosarcoma 
143B cybrids. The dashed line (100%) represents 
the mean value in each of the untreated cybrids. 
The bars indicate the percentage of treated 
cybrids. Error bars represent the standard devia-
tion. Om, osteosarcoma with mutation; Owti, 
isogenic wild-type osteosarcoma.
*p < 0.05 versus the same untreated cybrid.
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(Gómez-Durán et al. 2010, 2012; McKenzie 
et al. 2007; Zhang et al. 2012), and 3.15 μM 
OLI produced a decline in ATP produc-
tion in these 143B cybrids (Gómez-Durán 
et al. 2010, 2012; McKenzie et al. 2007). 
Furthermore, 3.15 μM OLI increased and 
6 μM OLI decreased MIMP in osteosarcoma 
143B cybrids (McKenzie et al. 2007; Porcelli 
et al. 2009). Surprisingly, in the present study, 
a qualitative assessment suggested that MIMP 
was reduced in Awt cybrids in response to 
16 nM OLI but was reduced in Am cybrids 
in response to only 4 nM OLI (Figure 6A). 
OLI may have caused a decrease in MIMP 
because there was insufficient ATP to activate 
respiratory substrates (Brown et al. 1990). 
The effect of OLI on H2O2 levels also varies. 
Previous studies showed that 4 nM OLI 
increased H2O2 levels in mouse preadipocytes 
3T3-L1 (Carrière et al. 2003), and 16 nM 
OLI decreased H2O2 in hASCs (Llobet et al. 
2015b). In both Om and Owt cybrids, 16 nM 
OLI decreased H2O2 levels (Figure 6B). 
Similar to its effect on hASCs (Llobet et al. 
2015b), 16 nM OLI increased IDH activity 
in Om cybrids (Figure 6C). All of these results 
support CV as the target of TBTC (von 
Ballmoos et al. 2004). Further investigation is 
required to confirm the target of TBTC.
Discussion
TBTC is a potent algicide and molluscicide 
that was used in marine antifouling ship paints 
(Grün 2014). Because of its adsorbing efficacy 
on sediments, long half-life, and lipophilic 
nature, levels of TBTC were considerably high 
in marine sediments and fishes (Mitra et al. 
2014). Widespread environmental contamina-
tion of marine ecosystems with organotins 
began in the 1960s (Grün 2014). As a result, 
a global ban on the use of organotin-based 
antifouling paints was instituted from 2003 
onward (Grün 2014). However, environ-
mental contamination by organotins goes 
beyond aquatic ecosystems because these 
compounds are also used in industrial and 
agricultural activities (Grün 2014). Their 
slow rate of environmental degradation gives 
TBTC compounds the potential for bioaccu-
mulation in upper trophic species of the food 
chain. Indeed, several studies have found TBT 
concentrations in human blood in the range 
of 8.3–293 nM (Kannan et al. 1999; Whalen 
et al. 1999). This range is consistent with the 
TBTC concentrations used in the present 
study. However, TBT compounds may be 
metabolized to dibutyltin and other metabo-
lites (Boyer 1989), and TBT is rapidly cleared 
from blood. Thus, blood would not be the 
ideal biological compartment for estimating 
the butyltin burden in humans (Kannan et 
al., 1999). In liver samples from 9 Polish, 4 
Japanese, and 18 Danish individuals, ranges 
of 2.4–11, 59–96, and 1.1–33 ng of butyltin 
(TBT + DBT + MBT)/g of liver were found 
(Kannan and Falandysz 1997; Nielsen and 
Strand 2002; Takahashi et al. 1999).
Om and Owt cybrids (or Am and Awt 
cybrids) differ in their mtDNA genotypes. The 
phenotypic differences provoked by TBTC 
between cybrids from the same nuclear genetic 
background suggest that mtDNA is the 
responsible factor. For the analysis of all mito-
chondrial variables, except oxygen consump-
tion, in osteosarcoma 143B cybrids, we used 
isogenic cybrids (Owti and Om). The Owti 
cybrid differred from the Om cybrid only at 
the m.8993 nucleotide position. Our results 
suggest that this mtDNA nucleotide position 
is the factor responsible for the phenotypic 
differences in response to TBTC between 
these cells. Moreover, there was greater simi-
larity in the mitochondrial response to TBTC 
between the Om and Am cybrids (or between 
Owt/Owti and Awt cybrids), which harbor 
different nDNA and mtDNA but the same 
m.8993 nucleotide, than between Om and 
Owt/Owti cybrids (or Am and Awt cybrids), 
which harbor the same nDNA or even the 
same mtDNA but differ at the m.8993 
nucleotide. These results confirm that the 
m.8993T>G transversion was the responsible 
factor for the phenotypic differences between 
these cells in response to TBTC. Therefore, 
a combination of this pathological mutation 
and this environmental contaminant could 
modify the phenotypic expression of the 
m.8993T>G mutation.
Several p.MT-ATP6 TMH4 and 5 
amino acids from the CV proton channel are 
mutated in patients suffering from different 
mitochondriopathies (López-Gallardo 
Figure 5. Isocitrate dehydrogenase (IDH) activity in 
tributyltin chloride (TBTC)-treated osteosarcoma 
143B cybrids. The dashed line (100%) represents 
the mean value in each of the untreated osteo-
sarcoma 143B cybrids. The bars indicate the 
percentage of treated cybrids. Error bars represent 
the standard deviation. Om, osteosarcoma with 
mutation; Owti, isogenic wild-type osteosarcoma. 
*p < 0.05 versus the same untreated cybrid. #p < 0.05 ver-
sus the mutant cybrid treated with 20 nM TBTC.
Figure 6. Effects of oligomycin (Oli) on different mitochondrial parameters. (A) Mitochondrial inner 
membrane potential (MIMP) in single samples of treated adenocarcinoma A549 cybrids. Reduced red 
staining corresponds to a lower MIMP. The uncoupler carbonyl cyanide m-chlorophenyl hydrazone 
(CCCP) was used as a control because it decreases MIMP. (B) Hydrogen peroxide (H2O2) production in 
treated osteosarcoma 143B cybrids. (C) Isocitrate dehydrogenase (IDH) activity in treated osteosarcoma 
143B cybrids. The dashed line (100%) represents the mean value in each of the untreated osteosarcoma 
143B cybrids. The bars indicate the percentage of treated cybrids. Error bars represent the standard 
deviation. Am, adenocarcinoma with mutation; Awt, wild-type adenocarcinoma; Om, osteosarcoma with 
mutation; Owti, isogenic wild-type osteosarcoma.
*p < 0.05 versus the same untreated cybrid. #p < 0.05 versus the wild-type cybrid at the same OLI concentration.
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et al. 2014). The interaction of a particular 
mutation with an environmental factor, such 
as TBTC, may explain different pathological 
phenotypes. Interestingly, such an interaction 
might also explain why the m.9025G>A/p.
MT-ATP6:G167S mutation, a candidate 
for the etiologic factor of a particular mito-
chondriopathy, is found in both patients 
and healthy individuals. The m.9025G>A 
mutation was found in a patient with loss of 
Purkinje cells (López-Gallardo et al. 2014), 
and Purkinje cells showed degenerative 
changes throughout tributyltin-treated rat 
cerebellum (Elsabbagh et al. 2002).
Organotin compounds are highly lipo-
philic and readily penetrate the blood-brain 
barrier to enter the brain (Kotake 2012). An 
in vitro study reported that at a concentra-
tion of 30 nM, TBTC caused a significant 
decrease in MIMP in dissociated mixed cells 
from different parts of the rat brain. Cells 
from the striatum showed a higher suscep-
tibility than cells from other brain regions 
(Mitra et al. 2014). Brain lesions, particularly 
in the striatum, characterize a group of disor-
ders termed “striatal necrosis syndromes.” 
These disorders include familial bilateral 
striatal necrosis (FBSN), MILS, and NARP, 
and they can be caused by MT-ATP6 muta-
tions (Schon et al. 2001). Interestingly, we 
found that levels of oxygen consumption, 
MIMP, and ATP production in wild-type 
cybrids exposed to TBTC were similar to 
levels in cybrids with MT-ATP6 mutations 
before exposure to TBTC. More experi-
ments in primary cells, such as neurons, are 
required. However, our findings suggest that 
environmentally induced striatal necrosis 
syndromes caused by xenobiotics, such as 
organotins, may be possible.
Conclusion
Unusual exposures to environmental toxins, 
at appropriate times and concentrations, 
should also be considered in the diagnosis of 
rare diseases.
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